New Angiofibromas Research from Dmitry Rogachev National Medical Research Center for Pediatric Hematology Outlined [Neoadjuvant therapy of juvenile angiofibroma of the nasopharynx and base of the skull with good clinical outcome (clinical case)].

A recent study conducted at the Dmitry Rogachev National Medical Research Center for Pediatric Hematology focused on neoadjuvant therapy for juvenile angiofibroma, a vascular tumor that primarily affects children and young men. The study highlighted a case of a 16-year-old boy with severe symptoms who showed significant improvement after 9 months of treatment with Sirolimus. The research, published in the journal Opuholi golovy i šei, emphasized the successful clinical outcome of the neoadjuvant therapy in reducing the tumor size and improving the patient's vision. [Extracted from the article]